Decheng Capital as of June 30, 2024
Portfolio Holdings for Decheng Capital
Decheng Capital holds 24 positions in its portfolio as reported in the June 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Cg Oncology (CGON) | 52.8 | $172M | 5.5M | 31.57 | |
| Nuvation Bio (NUVB) | 6.2 | $20M | 7.0M | 2.92 | |
| Arcus Biosciences Incorporated (RCUS) | 4.1 | $13M | 870k | 15.23 | |
| Zentalis Pharmaceuticals (ZNTL) | 3.8 | $13M | 3.1M | 4.09 | |
| Krystal Biotech (KRYS) | 3.7 | $12M | 66k | 183.64 | |
| BeyondSpring SHS (BYSI) | 3.6 | $12M | 5.0M | 2.40 | |
| Illumina (ILMN) | 3.5 | $11M | 109k | 104.38 | |
| Merus N V (MRUS) | 3.2 | $11M | 179k | 59.17 | |
| Phathom Pharmaceuticals (PHAT) | 2.7 | $8.8M | 850k | 10.30 | |
| Newamsterdam Pharma Co Nv (NAMS) | 2.4 | $7.7M | 400k | 19.21 | |
| Helix Acquisition Corp | 2.2 | $7.3M | 167k | 43.97 | |
| 4d Molecular Therapeutics In (FDMT) | 2.2 | $7.3M | 348k | 20.99 | |
| Crinetics Pharmaceuticals In (CRNX) | 2.2 | $7.1M | 158k | 44.79 | |
| Cytokinetics (CYTK) | 1.6 | $5.1M | 94k | 54.18 | |
| Legend Biotech Corp- Adr (LEGN) | 1.3 | $4.4M | 99k | 44.29 | |
| Aura Biosciences (AURA) | 1.2 | $3.9M | 516k | 7.56 | |
| Equillium (EQ) | 0.9 | $3.1M | 4.4M | 0.69 | |
| GeneDx Holdings Corp. Com Cl A (WGS) | 0.8 | $2.7M | 104k | 26.14 | |
| Vera Therapeutics (VERA) | 0.8 | $2.5M | 70k | 36.18 | |
| Pyxis Oncology (PYXS) | 0.3 | $1.1M | 327k | 3.31 | |
| AtriCure (ATRC) | 0.2 | $610k | 27k | 22.77 | |
| Grail (GRAL) | 0.1 | $279k | 18k | 15.37 | |
| Nuvation Bio Warrants (NUVB.WS) | 0.0 | $103k | 646k | 0.16 | |
| Arcellx (ACLX) | 0.0 | $65k | 1.2k | 55.19 |
